Digested Fiber from Wheat Bran Induces cdk Inhibitors which Block Colon Epithelial Cells in G1

  • Eileen A. Friedman
  • Jingping Wang
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 470)


We have tested the hypothesis that short chain organic acids in the colon derived from dietary pectin, wheat bran, oat bran, and cellulose are protective against the development of colon cancer because they cause growth arrest by inducing cyclin-directed kinase (cdk) inhibitors. A more quiescent colonic epithelium is less susceptible to mutagens which can lead to mutations or deletions in the major genes implicated in the progression to colon cancer: ras, p53, and APC1 or in the genes involved in TGFβ response such as TβRII2 or the Smad genes which are intermediates in TGFβ signaling.3,4 TGFβ1 is a small protein found in vivo which is the most potent epithelial cell growth inhibitor known. High levels of TGFβ1 mRNA and peptide are found at the top of the colonic crypt in the region of terminally differentiated cells.5,6 Injected TGFβl shortens colonic crypts.7 These observations suggest that TGFβ1 induces differentiation and growth arrest in vivo. TGFβ1 inhibits colonocyte proliferation by inhibiting phosphorylation of the retinoblastoma protein through blocking the activity of cdk/cyclin complexes. TGFβ1 inhibits cdk kinases by inducing the cdk inhibitors p15 and p21 and causing accumulation of p27.8–10 Thus short chain organic acids in the colon derived from dietary fiber could act directly to induce cdk inhibitors, or they could work indirectly by first inducing TGFβl, which in turn induced cdk inhibitors.


Wheat Bran Sodium Butyrate Colonic Crypt Induce Growth Arrest Sodium Propionate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vogelstein, B. and Kinzler, K. p53 function and dysfunction. Cell 70:523–526, 1992.CrossRefPubMedGoogle Scholar
  2. 2.
    Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R., Zborowska, E., Kinzler, K., Vogelstein, B., Brattain, M., and Willson, J. Inactivation of the typeII TGFβ receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338, 1995.CrossRefPubMedGoogle Scholar
  3. 3.
    Massague, J. TGFβ signaling: receptors, transducers, and mad proteins. Cell 85:947–950, 1996.CrossRefPubMedGoogle Scholar
  4. 4.
    Hahn, S., Schutte, M., Hoque, A.T.M.S., Moskaluk, C., da Costa, L., Rozenblum, E., Weinstein, C., Fischer, A., Yeo, C., Hruban, R.H., and Kern, S. DPC4, a candidate tumor suppressor gene at human chromosome 18qa21.1. Science 271:350–353, 1996.CrossRefPubMedGoogle Scholar
  5. 5.
    Barnard, J., Lyons, R., and Moses, L. The cell biology of TGFβ. Biochem. Biophys. Acta. 1032:79–87, 1990.PubMedGoogle Scholar
  6. 6.
    Pelton, R., Saxena, B., Jones, M., Moses, H., and Gold, L. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115:1091–1105, 1991.CrossRefPubMedGoogle Scholar
  7. 7.
    Migdalska, A., Molineux, G., Demuynck, H., Evans, G., Ruscetti, F., and Dexter, T. Growth inhibitory effects of TGFβ1 in vivo. Growth Factors 4:239–245, 1991.CrossRefPubMedGoogle Scholar
  8. 8.
    Hannon, G. and Beach, D. pl5INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature 371:257–260, 1994.CrossRefPubMedGoogle Scholar
  9. 9.
    Li, C.-Y., Saurdet, L., and Little, J. Potential role of waf1/cip1/p21 as a mediator of TGFβ cytoinhibitory effect, J. Biol Chem. 270:4971–4974, 1995.CrossRefPubMedGoogle Scholar
  10. 10.
    Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. Kip/cip and ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGFβ. Genes Development 9:1831–1845, 1995.CrossRefPubMedGoogle Scholar
  11. 11.
    Hafez, M., Hsu, S., Yan, Z., Winawer, S., and Friedman, E. Two roles for TGFβl in colon enterocytic differentiation. Cell Growth Differ. 3:753–762, 1992.PubMedGoogle Scholar
  12. 12.
    Lupton, J. and Kurtz, P. Relationship of colonic luminal short-chain fatty acids and pH to in vivo cell proliferation in rats. J. Nutr. 123:1522–1530, 1993.PubMedGoogle Scholar
  13. 13.
    Zhang, J. and Lupton, J. Dietary fibers stimulate colonic cell proliferation by different mechanisms at different sites. Nutr. Cancer 22:267–276, 1994.CrossRefPubMedGoogle Scholar
  14. 14.
    Boffa, L., Lupton, J., Marianai, M., Ceppi, M., Newmark, H., Scalmati, A., and Lipkin, M. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res. 52:5906–5912, 1992.PubMedGoogle Scholar
  15. 15.
    Lee, D.-Y., Chapkin, R., and Lupton, J. Dietary fat and fiber modulate colonic cell proliferation in an interactive site-specific manner. Nutr. Cancer 20:107–118, 1993.CrossRefPubMedGoogle Scholar
  16. 16.
    El-Deiry, W., Tokino, T, Velculescu, V., Levy, D., Parsons, R., Trent, J., Lin, D., Mercer, W., Kinzler, K., and Vogelstein, B. Waf1, a potential mediator of p53 tumor suppression. Cell 75:817–825, 1993.CrossRefPubMedGoogle Scholar
  17. 17.
    Harper, J., Adami, C., Wei, N., Keyomarsi, K., and Elledge, S. The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816, 1993.CrossRefPubMedGoogle Scholar
  18. 18.
    Lee, M.H., Reynisdottir, I., and Massague, J. Cloning of p57kip2 a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Development 9:639–649, 1995.CrossRefPubMedGoogle Scholar
  19. 19.
    Hirai, H., Roussel, M.F., Kato, J.-Y., Ashmun, R.A., and Scherr, C.J. ink4 proteins pl8 and pl9 are specific inhibitors of the cyclin D-dependent kinases cdk4 and cdk6. Mol. Cell Biol. 15:2672–2681, 1995.PubMedGoogle Scholar
  20. 20.
    Orlow, I., Iavarone, A., Crider-Miller, S., Bonilla, E, Latres, E., Lee, M., Gerald, W., Massague, J., Weiss-man, B., and Cordon-Cardo, C. Cyclin-dependent kinase inhibitor p27kip2 in soft tissue sarcomas and Wilms’ tumors. Cancer Res. 56:1219–1221, 1996.PubMedGoogle Scholar
  21. 21.
    Nigg, E. Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair, and cell cycle control? Curr. Opin. Cell Biol. 8:312–317, 1996.CrossRefPubMedGoogle Scholar
  22. 22.
    Higashi, H., Suzuki-Takahashi, I., Saitoh, S., Segawa, K., Taya, Y., Okuyama, A., Nishimura, S., and Kitawgawa, M. Cdk2 forms an inactive complex with cyclin D1 since cdk2 associated with cyclin D1 is not phosphorylated by cdk2-cyclin H. Eur. J. Biochem. 237:460–467, 1996.CrossRefPubMedGoogle Scholar
  23. 23.
    Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J., Tempst, P., and Massague, J. Cloning of p27kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66, 1994.CrossRefPubMedGoogle Scholar
  24. 24.
    Schroy, P., Rifkin, J., Coffey, R., Winawer, S., and Friedman, E. Role of TGFβl in induction of colon carcinoma differentiation by HMBA. Cancer Res. 50:261–265, 1990.PubMedGoogle Scholar
  25. 25.
    Van Obberghen-Schilling, E., Rochen, N.S., Flanders, K.C., Sporn, M., and Roberts, A. TGFβl positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263:7741–7746, 1988.PubMedGoogle Scholar
  26. 26.
    Nixon, D. Diet and chemoprevention of colon polyps and colorectal cancer. Sem. Surg. Oncol. 11:411–415, 1995.CrossRefGoogle Scholar
  27. 27.
    Alberts, D., Titenbaugh, C., Story, J., Aickin, M., Rees-McGee, S., Buller, M., Atwood, J., Phelps, J., Ramanujam, P., Bellapravalu, S., Patel, J., Bexttinger, L., and Clark, L. Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps. J. Natl. Cancer Inst. 88:81–92, 1996.CrossRefPubMedGoogle Scholar
  28. 28.
    Datto, M., Li, Y., Panus, J., Howe, D., Xiong, Y., and Wang, X. TGFβ induces the cdk inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545–5549, 1995.CrossRefPubMedGoogle Scholar
  29. 29.
    Nakano, K., Mizuno, T, Sowa, Y., Orita, T, Yoshino, T, Okuyama, Y., Fujita, T, Ohtani-Fujita, N., Mat-sukawa, Y., Tokino, T., Yamagishi, H., Oka, T., Nomura, H., and Sakai, T. Butyrate activates the waf1/cip1 gene promoter through SP1 sites in a p53 negative human colon cancer cell line. J. Biol. Chem. 272:22199–22206, 1997.CrossRefPubMedGoogle Scholar
  30. 30.
    Oh, Y., Muller, H., Ng, L., and Rosenfeld, R. TGFβ induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein 3 action. J. Biol. Chem. 270:13589–13592, 1995.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Eileen A. Friedman
    • 1
  • Jingping Wang
    • 1
  1. 1.Department of PathologyState University of New York Health Science Center at SyracuseSyracuseUSA

Personalised recommendations